Hertility Health secures investment from Emma Watson to advance reproductive healthcare.
The funding follows the company's ongoing efforts to close gaps in women's healthcare and hormonal testing.
Hertility Health provides comprehensive hormonal testing, fertility insights, and healthcare support for women. The company uses a science-driven platform to make reproductive healthcare more accessible, affordable, and personalised.
Hertility Health has secured an investment from actress and activist Emma Watson. The funding supports the company in its mission to transform how women understand and manage reproductive health, addressing widespread gaps in care for conditions such as polycystic ovary syndrome, endometriosis, and infertility.
Founded to improve access to reproductive healthcare, Hertility combines innovative diagnostic home testing kits with a digital platform and virtual clinic. The investment arrives as the company continues to advocate for greater awareness around women's health and productivity, noting that the vast majority of women experience reproductive health issues during their lives.
From the founder
"Emma's investment is a powerful endorsement of the importance of our mission. We believe in breaking down the barriers that prevent women from accessing reproductive healthcare, and with Emma's support, we are one step closer to achieving that vision."
Dr. O'Neill
CEO at Hertility Health
Investor perspective
"We want to end gender inequality and to do that, we need everyone involved"
Emma Watson
Activist and Investor, Emma Watson
Investors
Categories
About the company
Hertility Health
Hertility Health offers comprehensive hormonal testing, fertility insights, and reproductive healthcare support.